Chronic Fatigue Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with breast cancer (stages 0 to III) that has not spread to other parts of the body, confirmed by a tissue sample examination.
- You are a woman between 19 and 80 years old with breast cancer.
- You are due to start, or have started within the last 3 months, hormone therapy, chemotherapy, and/or radiation therapy as part of your breast cancer treatment.
- Your doctors expect you to live beyond at least 3 months after starting treatment.
- You are able to understand what the study involves and are willing and able to attend follow-up appointments.
- You do not have any personal, family, social, or location-related circumstances that would make it difficult to follow the study plan and attend check-ins.
Who may not be able to join:
- You are a man with breast cancer.
- You do not agree to follow the study plan.
- You have previously been diagnosed with another type of cancer (note: skin cancer that was treated with surgery alone may still be acceptable — confirm with trial site).
- You have previously received chemotherapy or radiation therapy for any reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Svein Skeie, PhD, Helse Stavanger HF
Phone: 47861295
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Level of fatigue at diagnosis - baseline; Change from baseline fVAS after treatment 6 months; fVAS follow up 12 months; fVAS follow up 18 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.